Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch [Seeking Alpha]
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: Seeking Alpha
Cytisinicline's a4ß2 partial agonism aims to reduce cravings and blunt nicotine reward. In fact, the most promising aspect of cytisinicline was that its Phase 3 ORCA trials showed strong quit-rate deltas versus placebo. Thus, ACHV's bull thesis now hinges on FDA approval and a potential subsequent launch by 2H2026. Given cytisinicline's promising effectiveness and safety profile, coupled with a near-term catalyst, I ultimately lean towards a speculative "Buy" at these levels. Benoit Bacou/Photononstop via Getty Images Achieve Life Sciences, Inc. ( ACHV ) is a pharmaceutical company developing cytisinicline, a candidate designed to treat nicotine dependence. Its lead program targets adult smoking cessation, with an accepted NDA and a PDUFA date of June 20, 2026. The NDA This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 7
Show less
Read more
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy [Seeking Alpha]Seeking Alpha
- Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences Announced Granting of New Hire Inducement AwardsGlobeNewswire
- Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical OfficerGlobeNewswire
ACHV
Earnings
- 11/6/25 - Miss
ACHV
Sec Filings
- 1/30/26 - Form 4
- 1/30/26 - Form 4
- 1/30/26 - Form 4
- ACHV's page on the SEC website